Search research articles
Contact Us
Filters
Showing results (151-160 of 234) with videos related to
Page
of 24
Sort By:
Urologic Oncology
|
July 15, 2020
Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival
Camilla M Grunewald, Alina Henn, Matthew D Galsky, et al.
Clinical Genitourinary Cancer
|
January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Lauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
The Journal of Urology
|
July 18, 2018
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma
Guru P Sonpavde, Luigi Mariani, Salvatore Lo Vullo, et al.
Nature Reviews. Urology
|
September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Elaine Chang, Andrea B Apolo, Rick Bangs, et al.
The Oncologist
|
August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
Risa L Wong, Lorin A Ferris, Olivia A Do, et al.
Journal for Immunotherapy of Cancer
|
August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
European Urology
|
December 17, 2022
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26]
Evan Y Yu, Josep M Piulats, Gwenaelle Gravis, et al.
Cancer
|
February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel
Rana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Page
of 24
Search research articles
Search
Showing results (151-160 of 234) with videos related to
Sort By:
Page
of 24
Urologic Oncology
|
July 15, 2020
Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival
Camilla M Grunewald, Alina Henn, Matthew D Galsky, et al.
Clinical Genitourinary Cancer
|
January 1, 2018
Contemporary Patterns of Multidisciplinary Care in Patients With Muscle-invasive Bladder Cancer
Lauren C Harshman, Abhishek Tripathi, Matthew Kaag, et al.
The Journal of Urology
|
July 18, 2018
Impact of the Number of Cycles of Platinum Based First Line Chemotherapy for Advanced Urothelial Carcinoma
Guru P Sonpavde, Luigi Mariani, Salvatore Lo Vullo, et al.
Nature Reviews. Urology
|
September 11, 2021
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
Elaine Chang, Andrea B Apolo, Rick Bangs, et al.
The Oncologist
|
August 6, 2021
Efficacy of Platinum Rechallenge in Metastatic Urothelial Carcinoma After Previous Platinum-Based Chemotherapy for Metastatic Disease
Risa L Wong, Lorin A Ferris, Olivia A Do, et al.
Journal for Immunotherapy of Cancer
|
August 28, 2021
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC)
Russell K Pachynski, Chihiro Morishima, Russell Szmulewitz, et al.
JCI Insight
|
May 31, 2019
Genomic distinctions between metastatic lower and upper tract urothelial carcinoma revealed through rapid autopsy
Brian R Winters, Navonil De Sarkar, Sonali Arora, et al.
European Urology Oncology
|
June 26, 2024
Pembrolizumab plus Abiraterone Acetate and Prednisone in Patients with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Results from KEYNOTE-365 Cohort D
Evan Y Yu, Cristiano Ferrario, Mark D Linch, et al.
European Urology
|
December 17, 2022
Corrigendum to "Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A Study" [Eur Urol 83 (2023) 15-26]
Evan Y Yu, Josep M Piulats, Gwenaelle Gravis, et al.
Cancer
|
February 11, 2026
Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel
Rana R McKay, Benjamin L Maughan, Alicia K Morgans, et al.
Page
of 24